None
EN
Dyne Therapeutics (NASDAQ:DYN) Releases Earnings Results, Misses Expectations By $0.34 EPS
['Tyrone Williams']
Daily Political
Dyne Therapeutics (NASDAQ:DYN – Get Free Report) posted its earnings results on Wednesday.
Dyne Therapeutics Stock Down 3.1%Shares of NASDAQ DYN traded down $0.80 during midday trading on Wednesday, reaching $25.10.
Dyne Therapeutics has a 52-week low of $9.32 and a 52-week high of $26.26.
Weiss Ratings reissued a “sell (d-)” rating on shares of Dyne Therapeutics in a research report on Friday, July 17th.
Further ReadingReceive News & Ratings for Dyne Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dyne Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.